Valuation: Bayer AG

Market Cap 46.88B 53.63B 43.36B 39.78B 75.3B 5,168B 76.61B 517B 203B 2,524B 201B 197B 8,713B P/E 2026 *
20.6x
P/E 2027 * 15.4x
Enterprise Value 78.72B 90.06B 72.8B 66.81B 126B 8,678B 129B 868B 341B 4,238B 338B 331B 14,631B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.48%
Yield 2027 * 1.32%
1 week-5.00%
Current month+1.67%
1 month+35.32%
3 months+17.52%
6 months+18.27%
Current year+34.42%
1 week 205.3
Extreme 205.3
223.1
1 month 157.05
Extreme 157.05
230.5
3 years 78.97
Extreme 78.97
241
Manager TitleAgeSince
Chief Executive Officer 59 01/06/2023
Director of Finance/CFO 57 01/06/2026
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.77%-5.00%+76.78%-9.49% 53.63B
+1.08%-3.93%+48.03%+160.13% 1,043B
+1.19%-3.52%+51.70%+56.36% 602B
+4.21%+1.79%+33.48%+87.04% 449B
+0.80%-0.30%+30.58%+25.13% 327B
+1.12%+0.55%+33.88%+47.15% 279B
-0.48%-1.95%+22.03%+23.37% 264B
+3.70%+2.19%+24.27%+63.38% 201B
+3.49%+1.08%+24.08%+76.58% 169B
+1.29%+3.67%+2.15%-30.78% 143B
Average +0.94%-0.68%+34.70%+49.89% 386.34B
Weighted average by Cap. +0.69%-1.82%+38.20%+81.65%

Financials

2026 *2027 *
Net sales 45.6B 52.17B 42.17B 38.7B 73.25B 5,027B 74.52B 503B 198B 2,455B 196B 192B 8,476B 46.76B 53.49B 43.24B 39.68B 75.1B 5,154B 76.4B 516B 203B 2,517B 201B 196B 8,690B
Net income 2.13B 2.43B 1.97B 1.8B 3.41B 234B 3.47B 23.45B 9.21B 114B 9.13B 8.93B 395B 2.93B 3.35B 2.71B 2.49B 4.71B 323B 4.79B 32.34B 12.71B 158B 12.6B 12.32B 545B
Net Debt 31.84B 36.43B 29.45B 27.02B 51.14B 3,510B 52.03B 351B 138B 1,714B 137B 134B 5,918B 28.71B 32.85B 26.55B 24.37B 46.12B 3,165B 46.92B 317B 124B 1,546B 123B 121B 5,336B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Date Price Change
17/07/26 PLN 205.30 -0.77%
16/07/26 PLN 206.90 -1.71%
15/07/26 PLN 210.50 -2.55%
14/07/26 PLN 216.00 0.00%
13/07/26 PLN 216.00 -0.83%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.72EUR
Average target price
54.92EUR
Spread / Average Target
+15.08%

Quarterly revenue - Rate of surprise